Education Information
2014 - 2023
2014 - 2023Doctorate
Erciyes University, Sağlık Bilimleri Enstitüsü, --, Turkey
2010 - 2012
2010 - 2012Postgraduate
Umea Universitet (Umea University), Medical Faculty , Molecular Biology , Sweden
2005 - 2009
2005 - 2009Undergraduate
University of Development Alternative , Life science , Biotechnology and Genetic Engineering , Bangladesh
Dissertations
2023
2023Doctorate
DEVELOPMENT AND EFFICACY ASSESSMENT OF TWO RECOMBINANT ADENOVIRUS-BASED VACCINE CANDIDATES AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER
Erciyes University, Sağlık Bilimleri Enstitüsü, --
2012
2012Postgraduate
Francisella is sensitive to insect antimicrobial peptides
Umea Universitet (Umea University), Medical Faculty, Molecular Biology
Foreign Languages
A2 Elementary
A2 ElementaryHindi
C1 Advanced
C1 AdvancedEnglish
C2 Mastery
C2 MasteryBengali
Certificates, Courses and Trainings
2017
2017AKTA chromatography systems workshop arranged
Health&Medicine
GE Healthcare
2017
2017workshop on Molecular Phylogenetics
Health&Medicine
Erciyes University
2011
2011Basic Course in Transmission and Scanning Electron Microscope
Health&Medicine
Umea University, Sweden
Research Areas
Microbiology
Virology
Academic Titles / Tasks
2020 - Continues
2020 - ContinuesLecturer
Erciyes University, Rektörlük, --
2012 - 2013
2012 - 2013Research Assistant
Umea Universitet (Umea University), Medical Faculty, Molecular Biology
Non Academic Experience
2019 - 2020
2019 - 2020Expert Researcher
Special Research Center, Erciyes University
Published journal articles indexed by SCI, SSCI, and AHCI
2023
2023Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials
Ozdarendeli A., Sezer Z., Pavel S. T. I., Inal A., Yetiskin H., Kaplan B., et al.
VACCINE
, vol.41, no.2, pp.380-390, 2023 (SCI-Expanded)
2023
2023Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants
Mamedov T., Yuksel D., Gurbuzaslan I., Ilgin M., Gulec B., Mammadova G., et al.
FRONTIERS IN PLANT SCIENCE
, vol.14, 2023 (SCI-Expanded)
2023
2023SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants
Mamedov T., Yuksel D., Gurbuzaslan I., Gulec B., Mammadova G., Özdarendeli A., et al.
Frontiers in Plant Science
, vol.14, 2023 (SCI-Expanded)
2022
2022Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
Taşlı N. P., Gönen Z. B., Kırbaş O. K., Gökdemir N. S., Bozkurt B. T., Bayrakçı B., et al.
FRONTIERS IN IMMUNOLOGY
, vol.13, pp.1-15, 2022 (SCI-Expanded)
2022
2022Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2
Yetişkin H., Kaplan B., Pavel S. T. I., Özdarendeli A.
FRONTIERS IN IMMUNOLOGY
, vol.13, pp.824378, 2022 (SCI-Expanded)
2021
2021Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19
Mamedov T., Yuksel D., Ilgın M., Gürbüzaslan I., Gulec B., Mammadova G., et al.
VACCINES
, vol.9, no.11, 2021 (SCI-Expanded)
2021
2021Development of an Inactivated Vaccine against SARS CoV-2
Pavel S. T. I., Yetiskin H., Uygut M. A., Aslan A. F., Aydın G., Inan Ö., et al.
VACCINES
, vol.9, no.11, 2021 (SCI-Expanded)
2021
2021Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice
Mamedov T., Yuksel D., Ilgın M., Gurbuzaslan I., Gulec B., Yetiskin H., et al.
VIRUSES-BASEL
, vol.13, no.8, 2021 (SCI-Expanded)
2020
2020Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model
Pavel S. T. I., Yetiskin H., Kalkan A., Ozdarendeli A.
PLOS NEGLECTED TROPICAL DISEASES
, vol.14, no.11, 2020 (SCI-Expanded)
2020
2020Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey
PAVEL S. T. I., YETİŞKİN H., AYDIN G., Holyavkin C., UYGUT M. A., Dursun Z. B., et al.
PLoS ONE
, vol.15, 2020 (SCI-Expanded)
2020
2020Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
Alm E., Broberg E. K., Connor T., Hodcroft E. B., Komissarov A. B., Maurer-Stroh S., et al.
Eurosurveillance
, vol.25, no.32, 2020 (SCI-Expanded)
2013
2013Francisella is sensitive to insect antimicrobial peptides.
Vonkavaara M., Pavel S. T. I., Hölzl K., Nordfelth R., Sjöstedt A., Stöven S.
Journal of innate immunity
, vol.5, pp.50-9, 2013 (SCI-Expanded)
Refereed Congress / Symposium Publications in Proceedings
2019
2019Comparing Immunogenicity and Protective Efficacy of Cell Culture Based and Mice Brain Derived Inactivated Vaccine of Crimean Congo Haemorrhagic Fever Virus in Transiently Immune Suppressed Balb/c Mouse Model
YETİŞKİN H., pavel S. T. I., ÖZDARENDELİ A.
ScanVir2019, 3 - 05 June 2019
2015
2015Determination of the Vaccine Induced Immunodominant Regions of Nucleoprotein Crimean CongoHemorrhagic Fever Virus
BERBER E., ÇANAKOĞLU N., SÖZDUTMAZ İ., ÇALIŞKAN M., PAVEL S. T. I., YETİŞKİN H., et al.
ICVID 2015: International Conference on Virology and Infectious Diseases, Londrina, United Kingdom, 25 - 26 September 2015, vol.2, pp.975
Books & Book Chapters
2023
2023İnaktif Viral Aşılar
ÖZDARENDELİ A., PAVEL S. T. I., YETİŞKİN H., UYGUT M. A., KAPLAN B.
in: AŞI ÇALIŞMALARI VE TEKNOLOJİSİ, Mert Döşkaya ,Adnan Yüksel Gürüz, Ayşe Gülten Kantarcı, Cemal Ün, Editor, Nobel Tıp Kitabevleri Tic. Ltd. Şti., İstanbul, pp.285-298, 2023
Supported Projects
2022 - Continues
2022 - Continues
Covid19a karşı bivalent ve trivalent inaktif aşı geliştirilmesi
Project Supported by Higher Education Institutions
ÖZDARENDELİ A. (Executive), KAPLAN B., YETİŞKİN H., UYGUT M. A., PAVEL S. T. I.
2022 - Continues
2022 - Continues
Covid-19'a karşı Bakülovirus tabanlı ekspresyon sisteminin geliştirilmesi ve biyolojik aktivitesinin araştırılması
Project Supported by Higher Education Institutions
ÖZDARENDELİ A. (Executive), AYDIN G., PAVEL S. T. I., YETİŞKİN H., KAPLAN B., UYGUT M. A., et al.
2021 - Continues
2021 - Continues
TURKOVAC aşısının Delta varyantına karşı koyuculuğunun saptanması
Project Supported by Higher Education Institutions
ÖZDARENDELİ A. (Executive), PAVEL S. T. I., ASLAN A. F., YETİŞKİN H., KAPLAN B.
Patent
2021
2021COVID-19'A KARŞI GELİŞTİRİLEN HÜCRE KÜLTÜR TABANLI İNAKTİF AŞI
Patent
Pending / Applied, The Invention Recourse Number: 2021/014461 , Standard Registration
2020
2020Universal crimean congo haemorrhagic fever virus (cchfv) vaccine
Patent
Pending / Applied, The Invention Recourse Number: PCT/TR2020/050428 , Standard Registration
2019
2019KIRIM-KONGO KANAMALI ATEŞ HASTALIĞINA (KKKAH) KARŞI REKOMBİNANT AŞI GELİŞTİRİLMESİ
Patent
Standard Registration
Awards
September 2013
September 2013Stipend and Travel Grant
Marie Curie Actions/Fp7
June 2013
June 2013Travel grant and stipend
Odessa I. I. Mechnikov National University
August 2012
August 2012Travel Grant
Daad (German Academic Exchange Service)
Congress and Symposium Activities
03 June 2019 - 05 June 2019
03 June 2019 - 05 June 2019Scanvir Conference
Attendee
Turku-Finland
25 September 2015 - 28 September 2015
25 September 2015 - 28 September 2015
ICVID 2015: 17th International Conference on Virology and Infectious Diseases
Attendee
London-United Kingdom
Scholarships
2010 - 2012
2010 - 2012Full free scholarship for completing the post graduate
University
2005 - 2009
2005 - 2009